| Literature DB >> 36009626 |
Romi Novriadi1, Oriol Roigé2, Sergi Segarra2.
Abstract
This study evaluated the effects of dietary nucleotide supplementation in Pacific white shrimp, Litopenaeus vannamei, cultured in Indonesia. A total of 22,500 shrimp receiving diets in which fish meal (FM) had been partially replaced with vegetable protein sources were classified into five study groups (4500 shrimp/group) and received different diets for 110 days: 10FM (control group; 10% FM), 6FM (6% FM-low FM and no nucleotide supplementation), 10FMN (10% FM; 0.1% nucleotides), 8FMN (8% FM; 0.1% nucleotides) and 6FMN (6% FM; 0.1% nucleotides). Growth performance, body composition, total hemocyte count (THC), lysozyme activity, and hepatopancreas histopathology were assessed. Organoleptic evaluation and profitability assessments were also performed. In addition, shrimp resistance to a Vibrio harveyi challenge was studied in shrimps after having received the diets for 30 days. Results showed that reducing FM had a negative impact on growth performance and hepatopancreas morphology. Adding nucleotides resulted in better performance and profitability, a healthier histomorphological appearance of the hepatopancreas, and significantly higher survival rates upon challenge with V. harveyi, while it did not negatively affect organoleptic parameters. In conclusion, nucleotide supplementation could be useful for optimizing performance, profitability, and disease resistance in shrimp cultured under intensive outdoor pond conditions.Entities:
Keywords: Pacific white shrimp; Vibrio harveyi; crustacean aquaculture; disease resistance; growth performance; nucleotides; nutrition; profitability
Year: 2022 PMID: 36009626 PMCID: PMC9404417 DOI: 10.3390/ani12162036
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
Composition (%, as is) of diets used in the study. Diets were administered to Pacific white shrimp (PWS) for 110 days, and were formulated using different levels (10%, 8% and 6%) of fish meal (FM), and with or without adding dietary nucleotides (N).
| Ingredient (%, | Diet | ||||
|---|---|---|---|---|---|
| 10FM | 6FM | 10FMN | 8FMN | 6FMN | |
| Menhaden fish meal 1 | 10.00 | 6.00 | 10.00 | 8.00 | 6.00 |
| Soybean meal 1 | 43.00 | 49.50 | 43.00 | 44.80 | 49.50 |
| Corn gluten meal 1 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Menhaden fish oil 1 | 5.64 | 5.64 | 5.64 | 5.64 | 5.64 |
| Soy-Lecithin 2 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Nucleotides 3 |
|
|
|
|
|
| Corn starch 1 | 8.06 | 5.56 | 7.96 | 8.16 | 5.46 |
| Wheat products 4 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 |
| Mineral premix 2* | 0.70 | 0.70 | 0.70 | 0.70 | 0.70 |
| Vitamin premix 2# | 1.90 | 1.90 | 1.90 | 1.90 | 1.90 |
| KP-dibasic 2 | 2.50 | 2.50 | 2.50 | 2.50 | 2.50 |
| Choline chloride 2 | 0.20 | 0.20 | 0.20 | 0.20 | 0.20 |
|
| 13.137 | 12.727 | 13.688 | 13.489 | 13.278 |
|
| 0.9178 | 0.8892 | 0.9553 | 0.9414 | 0.9267 |
10FM (control group; 10% FM), 6FM (6% FM and no nucleotide supplementation), 10FMN (10% FM; 0.1% nucleotides), 8FMN (8% FM; 0.1% nucleotides) and 6FMN (6% FM; 0.1% nucleotides). 1 PT FKS Multi Agro, Tbk. Jakarta, Indonesia. 2 PT Fenanza Putra Perkasa, Jakarta, Indonesia. 3 Nucleoforce®, Bioiberica, S.A.U, Palafolls, Spain. 4 PT Pundi Kencana, Cilegon, Banten, Indonesia. 5 Currency conversion on 15 January 2022: USD 1 = IDR 14.310. * Mineral premix (g/100 g premix): 0.004 cobalt chloride, 0.550 cupric sulfate pentahydrate, 2.000 ferrous sulfate, 13.862 magnesium sulfate anhydrous, 0.650 manganese sulfate monohydrate, 0.067 potassium iodide, 0.010 sodium selenite, 3.193 zinc sulfate heptahydrate, and 69.664 alpha-cellulose. # Vitamin premix (g/kg premix): 4.95 thiamin·HCL, 3.83 riboflavin, 4.00 pyridoxine HCL, 10.00 Ca-pantothenate, 10.00 nicotinic acid, 0.50 biotin, 4.00 folic acid, 0.05 cyanocobalamin, 25.00 inositol, 0.32 vitamin A acetate (500,000 IU/g), 80.00 vitamin D3 (1,000,000 IU/g), 0.50 menadione, and 856.81 alpha-cellulose.
Proximate analysis, calories, and amino acid (AA) composition (% as is, dry matter basis) of experimental diets utilized in this trial. Diets were administered to Pacific white shrimp (PWS) for 110 days, and were formulated using different levels (10%, 8% and 6%) of fish meal (FM), and with or without adding dietary nucleotides (N).
| Diet Code | |||||
|---|---|---|---|---|---|
| 10FM | 6FM | 10FMN | 8FMN | 6FMN | |
| Proximate analysis (%, | |||||
| Protein content | 36.55 | 36.07 | 36.95 | 36.57 | 35.99 |
| Fat content | 6.75 | 6.00 | 6.07 | 6.28 | 6.22 |
| Moisture content | 7.64 | 7.58 | 8.70 | 9.08 | 9.23 |
| Crude fiber | 2.69 | 3.40 | 1.75 | 1.91 | 1.63 |
| Calories (kcal/100 g) * | |||||
| Calories from fat | 60.75 | 54.00 | 54.63 | 56.52 | 64.98 |
| Total calories | 362.47 | 350.32 | 343.67 | 345.32 | 350.82 |
| Amino acid profile (%, | |||||
| L-Serine | 1.92 | 2.09 | 2.28 | 2.18 | 1.97 |
| L-Glutamic acid | 6.87 | 6.16 | 4.96 | 5.49 | 5.89 |
| L-Phenylalanine | 3.32 | 2.75 | 3.78 | 3.27 | 2.43 |
| L-Isoleusine | 1.26 | 1.41 | 1.41 | 1.39 | 1.39 |
| L-Valine | 1.37 | 1.53 | 1.56 | 1.51 | 1.50 |
| L-Alanine | 1.63 | 1.68 | 1.61 | 1.61 | 1.69 |
| L-Arginine | 2.48 | 2.88 | 3.49 | 3.21 | 2.63 |
| Glycine | 1.73 | 1.81 | 2.13 | 1.93 | 1.74 |
| L-Lysine | 2.86 | 1.71 | 1.60 | 1.80 | 2.23 |
| L-Aspartic acid | 3.00 | 3.25 | 2.52 | 2.79 | 3.27 |
| L-Leusine | 2.65 | 2.88 | 2.94 | 2.90 | 2.81 |
| L-Tyrosine | 1.36 | 1.63 | 2.30 | 2.05 | 1.45 |
| L-Proline | 2.02 | 2.05 | 2.00 | 2.01 | 2.01 |
| L-Threonine | 1.65 | 1.81 | 2.09 | 1.93 | 1.71 |
| L-Histidine | 1.05 | 1.22 | 1.62 | 1.43 | 1.12 |
| L-Cystine | 0.35 | 0.52 | 0.48 | 0.44 | 0.58 |
| L-Methionine | 0.65 | 0.67 | 0.68 | 0.68 | 0.68 |
| L-Tryptophan | 0.32 | 0.36 | 0.33 | 0.34 | 0.33 |
10FM (control group; 10% FM), 6FM (6% FM and no nucleotide supplementation), 10FMN (10% FM; 0.1% nucleotides), 8FMN (8% FM; 0.1% nucleotides) and 6FMN (6% FM; 0.1% nucleotides). * Analyses conducted by the Saraswanti Indo Genetech Laboratory, Bogor, West Java, Indonesia.
Figure 1Withdrawal of hemolymph performed on one of the Pacific white shrimp (PWS) from the study. Hemolymph was obtained from the pleopod base of the second abdominal segment by using a sterile 1-mL syringe and a 25 G × 13 mm needle.
Growth performance of Pacific white shrimp (PWS) fed diets supplemented with nucleotides (N) and different levels of replacement of fish meal (FM) by vegetable protein sources for 110 days. Values represent the mean of ten replicates. Results in the same columns with different superscript letter are significantly different (p < 0.05).
| Diet | Final Biomass (g) | FBW (g) | Survival Pre-Challenge (%) | PWG (%) | FCR | TGC | ADG |
|---|---|---|---|---|---|---|---|
| 10FM | 7604.0 | 20.05 a | 83.31 | 1904.66 a | 1.36 a | 0.05429 a | 0.173 a |
| 6FM | 7405.5 | 19.44 b | 83.91 | 1844.15 b | 1.40 b | 0.05341 b | 0.167 b |
| 10FMN | 7652.5 | 20.28 a | 83.84 | 1928.38 a | 1.34 a | 0.05462 a | 0.175 a |
| 8FMN | 7521.0 | 19.98 a | 84.67 | 1897.90 a | 1.37 a | 0.05419 a | 0.173 a |
| 6FMN | 7534.0 | 19.95 a | 83.93 | 1895.46 a | 1.37 a | 0.05415 a | 0.172 a |
| 0.1827 | <0.0001 | 0.9336 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
| PSE | 116.0961 | 0.1449 | 1.3703 | 14.4975 | 0.0106 | 0.0002 | 0.0013 |
10FM (control group; 10% FM), 6FM (6% FM and no nucleotide supplementation), 10FMN (10% FM; 0.1% nucleotides), 8FMN (8% FM; 0.1% nucleotides) and 6FMN (6% FM; 0.1% nucleotides), FBW (final body weight), PWG (percentage weight gain), FCR (feed conversion ratio), TGC (thermal growth coefficient), ADG (average daily growth in gram per day), PSE (pooled standard error).
Proximate composition (%, as is), calories from fat and total calories of feed (KCal 100 g−1), and amino acid profile (%, as is) of Pacific white shrimp (PWS) whole body at the end of the 110-day growth trial.
| Parameter | Unit | Nutritional Composition | |||||
|---|---|---|---|---|---|---|---|
| Control | 10FM | 6FM | 10FMN | 8FMN | 6FMN | ||
| Protein content | % | 24.89 | 22.42 | 22.29 | 24.72 | 24.88 | 23.65 |
| Total fat | % | 1.01 | 0.28 | 0.35 | 0.31 | 0.33 | 0.29 |
| Moisture content | % | 79.69 | 68.72 | 72.77 | 69.43 | 69.96 | 69.72 |
| Carbohydrate | % | 0.65 | 1.56 | 2.45 | 1.88 | 1.70 | 2.14 |
| Ash content | % | 3.76 | 1.59 | 1.78 | 1.71 | 2.27 | 1.82 |
| Calories from fat | KCal 100 g−1 | 4.09 | 4.41 | 4.38 | 4.20 | 4.41 | 4.58 |
| Total calories | KCal 100 g−1 | 71.25 | 113.53 | 109.34 | 111.45 | 115.77 | 110.66 |
| Crude fiber | % | 0.44 | <0.02 | <0.02 | <0.02 | <0.02 | <0.02 |
| L-Cystine | % | 0.23 | 6.44 | 5.31 | 6.02 | 6.14 | 5.89 |
| L-Methionine | % | 0.09 | 4.55 | 4.38 | 4.47 | 4.78 | 4.66 |
| L-Serine | % | 0.37 | 11.53 | 11.02 | 11.15 | 11.53 | 11.44 |
| L-Glutamic acid | % | 1.39 | 31.36 | 29.35 | 32.52 | 32.25 | 31.89 |
| L-Phenylalanine | % | 0.71 | 15.25 | 13.74 | 15.29 | 15.44 | 15.12 |
| L-Isoleucine | % | 0.39 | 11.15 | 10.95 | 11.44 | 10.87 | 10.99 |
| L-Valine | % | 0.45 | 10.77 | 10.82 | 11.34 | 11.33 | 10.39 |
| L-Alanine | % | 0.74 | 12.63 | 12.68 | 12.65 | 12.72 | 12.77 |
| L-Arginine | % | 0.40 | 28.44 | 23.11 | 28.65 | 28.23 | 26.44 |
| Glycine | % | 1.10 | 17.13 | 17.74 | 17.63 | 19.13 | 18.66 |
| L-Lysine | % | 0.53 | 14.56 | 14.22 | 15.07 | 14.37 | 14.44 |
| L-Aspartic acid | % | 0.75 | 16.89 | 17.02 | 18.45 | 17.23 | 16.89 |
| L-Leucine | % | 0.71 | 18.66 | 17.74 | 16.55 | 17.75 | 17.66 |
| L-Tyrosine | % | 0.52 | 11.41 | 10.39 | 10.45 | 10.48 | 10.59 |
| L-Proline | % | 0.41 | 18.78 | 18.85 | 19.02 | 19.11 | 18.59 |
| L-Threonine | % | 0.58 | 11.30 | 10.54 | 11.33 | 11.40 | 10.77 |
| L-Histidine | % | 0.40 | 7.77 | 7.42 | 7.51 | 7.96 | 7.88 |
| L-Tryptophan | % | 0.11 | 1.65 | 1.86 | 1.91 | 1.79 | 1.82 |
10FM (control group; 10% FM), 6FM (6% FM and no nucleotide supplementation), 10FMN (10% FM; 0.1% nucleotides), 8FMN (8% FM; 0.1% nucleotides) and 6FMN (6% FM; 0.1% nucleotides).
Figure 2Pacific white shrimp (PWS) total hemocyte count (106 cells/mL−1) at the end of the 110-day growth trial. 10FM (control group; 10% FM), 6FM (6% FM and no nucleotide supplementation), 10FMN (10% FM; 0.1% nucleotides), 8FMN (8% FM; 0.1% nucleotides) and 6FMN (6% FM; 0.1% nucleotides). Values represent the mean of ten replicates.
Figure 3Pacific white shrimp (PWS) lysozyme activity (U/mL−1) at the end of the 110-day growth trial. 10FM (control group; 10% FM), 6FM (6% FM and no nucleotide supplementation), 10FMN (10% FM; 0.1% nucleotides), 8FMN (8% FM; 0.1% nucleotides) and 6FMN (6% FM; 0.1% nucleotides). Values represent the mean of ten replicates.
Figure 4Representative histopathological images of hematoxylin and eosin-stained sections of the hepatopancreas from Pacific white shrimp (PWS) belonging to different study groups. 10FM (control group; 10% FM), 6FM (6% FM and no nucleotide supplementation), 10FMN (10% FM; 0.1% nucleotides), 8FMN (8% FM; 0.1% nucleotides) and 6FMN (6% FM; 0.1% nucleotides). The white arrow points to vacuolation observed in the 6FM group as a result of replacing fish meal with vegetable protein sources.
Figure 5(A) Evolution of mean survival rate in Pacific white shrimp (PWS) over time in each study group after challenge test with Vibrio harveyi infection at dose of 1 × 105 CFU mL−1, intramuscularly; (B) mean survival rate at the end of the challenge test. Different letters indicate statistically significant differences (p < 0.05) between the study groups. 10FM (control group; 10% FM), 6FM (6% FM and no nucleotide supplementation), 10FMN (10% FM; 0.1% nucleotides), 8FMN (8% FM; 0.1% nucleotides) and 6FMN (6% FM; 0.1% nucleotides).
Results of organoleptic assessment of Pacific white shrimp (PWS) fed with different diets for 110 days (n = 15 per group).
| Treatment | Observed Parameter | |||
|---|---|---|---|---|
| Color | Aroma | Flavor | Texture | |
| 10FM | 3.45 | 3.45 | 3.60 | 3.66 |
| 6FM | 3.35 | 3.35 | 3.46 | 3.35 |
| 10FMN | 3.65 | 3.55 | 3.66 | 3.65 |
| 8FMN | 3.40 | 3.46 | 3.55 | 3.55 |
| 6FMN | 3.45 | 3.66 | 3.55 | 3.35 |
| >0.05 | >0.05 | >0.05 | >0.05 | |
10FM (control group; 10% FM), 6FM (6% FM and no nucleotide supplementation), 10FMN (10% FM; 0.1% nucleotides), 8FMN (8% FM; 0.1% nucleotides) and 6FMN (6% FM; 0.1% nucleotides).